Call for Abstract
14th World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, will be organized around the theme “Emerging Concepts, Progressions and Awareness in Alzheimer’s Disease and Dementia”
Alzheimers Summit 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Alzheimers Summit 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Alzheimer's can be defined as a gradually progressive neurodegenerative disease characterized of memory impairment and subsequent disturbances in personality, mood, reasoning and perception. It caused by a combination of lifestyle, genetic, and environmental factors that gradually impairs the brain.
It can be diagnosed by evaluating subjects medical history, testing mental and mood status(NINCDS-ADRDA), lab tests and brain scans. An ongoing clinical trial conducted by Dominantly Inherited Alzheimer Network (DIAN), is to test whether antibodies to beta-amyloid can reduce the accumulation of beta-amyloid plaque in the brains with such genetic mutations and thereby reduce, delay or prevent symptoms and it can also be impeded by choosing the diet carefully.
- Track 1-1Neurological damage
- Track 1-2Cerebrospinal Fluid Biomarker
- Track 1-3Neuroimaging techniques
- Track 1-4Functional MRI (fMRI)
- Track 1-5Risk Factors Of Alzheimers
- Track 1-6Epidemiology
- Track 1-7Familial Alzheimer’s Disease (FAD)
- Track 1-8Disease-causing mutations
- Track 1-9Sporadic Alzheimer’s Disease
- Track 1-10Down Syndrome
- Track 1-11Medical And Lifestyle Exposures
- Track 1-12Obesity And Lack Of Physical Activity
- Track 1-13Genetic Risk Factors
Beta amyloid plaques and Neurofibrillary tangles of tau protein Pathology are prime suspects of neuronal cell death in Alzheimer’s it caused by accumulation of abnormally folded A-beta and tau proteins and Plaques of small peptides 39–43 amino acids to form Beta-amyloid which comprises amyloid precursor protein (APP) and a transmembrane protein that pierce the neuron's membrane. It later forms a fibrils of amyloid protein clump which get deposited in neurons to form a dense senile plaques, amyloid fibrils disrupts the cell’s calcium ions homeostasis and induces apoptosis of neurons which results in neurodegeneration affecting brain functioning.
- Track 2-1Neural networks, plasticity
- Track 2-2Cellular signalling, kinases, phosphatases, calcium
- Track 2-3Stem cells and Cell death
- Track 2-4Blood-brain barrier
- Track 2-5Oxidative damage and Mitochondrial dysfunction
- Track 2-6Cellular Signaling and cell to cell transmission
- Track 2-7Cholinergic Hypothesis
- Track 2-8Cerebral Amyloid Angiopathy
- Track 2-9Cerebrovascular Pathology
- Track 2-10Rapid Progression
- Track 2-11Pathogenesis Of Diabetic Nephropathy
- Track 2-12Tau Pathology of Alzheimers Disease
- Track 2-13Rehabilitation Therapies for Alzheimers Disease
- Track 2-14Cognitive Impairment and Neuroinflammation in Alzheimers Disease
- Track 2-15Pathogenesis of Alzheimers Disease
- Track 2-16Pathobiology of ApoE
More than 400 clinical trials are presently looking at new treatments for Alzheimer’s disease (AD) and many of them are actively recruiting. Many of the researches are based on decreasing the toxic effects of amyloid-beta in the brain, targeting amyloid production, blocking the accumulation of amyloid-beta into plaques, Aiming at Tau, Improving Cognition with Serotonin and Dietary Supplements.
- Track 3-1Preclinical Investigation to Clinical Trials
- Track 3-2Treatments Aimed at Reducing Symptoms
- Track 3-3Clinical trial design and methods
- Track 3-4Clinical trial design and methods
- Track 3-5Clinical Studies Of Alzheimers
- Track 3-6Quality of Life Trials
- Track 3-7Screening Trials
- Track 3-8Diagnostic Trials
- Track 3-9Prevention Trials
- Track 3-10Randomised Clinical Trials
Vascular dementia is the wider term for dementia associated with brain damage from impaired blood flow to the brain. The various types of dementia are Single-infarct, Multi-infarct dementia, Subcortical vascular dementia(Binswanger's disease), and Mixed dementia. Its clinical symptoms are Problems with planning or organising, concentrating, including short periods of sudden confusion and Memory, language and visuospatial skills also get affected.
Anyone can be affected by Vascular dementia, but several factors increase the risk. These include: High blood pressure, Smoking, Diabetes, High cholesterol, History of mild warning strokes, Evidence of disease in arteries elsewhere and Heart rhythm abnormalities, while no remedy can reverse the damage that has already been occurred, treatment to prevent extra strokes may be very essential.
- Track 4-1Dementia with Lewy bodies
- Track 4-2Progression and later stages
- Track 4-3Subcortical dementia
- Track 4-4Single-infarct and multi-infarct dementia
- Track 4-5Post-stroke dementia
- Track 4-6Stroke-related dementia
- Track 4-7Treatment and outcomes
- Track 4-8Causes and Risks factors
- Track 4-9Magnetic resonance imaging (MRI)
- Track 4-10Computerised tomography CT
- Track 4-11Amyotrophic Lateral Sclerosis
- Track 4-12Frontotemporal dementia
- Track 4-13Hallucinations or Delusions
Gerontology is scientific study of aging process and concerned with physical, mental, and social aspects and implications of aging. The field of gerontology is actually quite broader, containing many professionals who focus on different aspects of aging and development. Whereas it could be considered one large area, it actually consists of many minor fields all working together with a united focus on middle-aged and older adults.
Gerontologists include practitioners and researchers in the areas fields of nursing, medicine, criminology, biology, social work, physical and occupational therapy, psychology, sociology, psychiatry, dentistry, economics, political science, architecture, geography, pharmacy, public health, housing, and anthropology. There are several theories of aging includes Wear and tear theories, Genetic theories, General imbalance theories, Accumulation theories, free radical theory of aging, DNA damage theory of aging, Social theories of aging and Life course theory but none has been accepted.
- Track 5-1Cognitive and Functional Decline
- Track 5-2 Mitochondrial DNA mutations
- Track 5-3Hearing Loss
- Track 5-4Aging Network
- Track 5-5Healthcare and Aging
- Track 5-6Health and Wellness
- Track 5-7Aging and Mental Health
- Track 5-8Behavioral and Psychological Symptoms
- Track 5-9Gerontology and Geropsychologists
- Track 5-10Integrated Health Care
- Track 5-11Connecting With Caregivers
- Track 5-12Geriatrics Health and Caregiving
- Track 5-13Immune system with aging
- Track 5-14Frailty/Sarcopenia
- Track 5-15Hormonal Replacement
- Track 5-16Nutrition
- Track 5-17Mobility
- Track 5-18Depression
- Track 5-19Oxidative stress
Geriatric health care practice also known as "elder care health management, it is a process of planning and coordinating care of the old aged individuals and others with physical and/or mental abilities to meet their long term care needs, enhance their quality of life, and carried their independence for as long as possible. It involves in working with persons of old age and their families in managing, rendering and furnishing various types of health and social care services.
Awareness is attention plus working memory, it isn't always distinctive to humans, many animals display the traits of awareness, it's miles something that appears to have developed often in many lineages. And Awareness has a quite specific definition it's the capability of selecting particular aspects of the environment, and to be able cognitively to control these aspects over a more prolonged timescale than regular cognitive processing. Neural systems that controls and regulate to attenuate awareness in humans whose central and peripheral nervous system provides more instructions than cognitive sites in the brain can assimilate.
- Track 6-1Geriatric emergency medicine
- Track 6-2Geriatric neurology
- Track 6-3Geriatric psychiatry
- Track 6-4support devices & monitoring
- Track 6-5caregiver support
Cognitive neuroscience is scientific study of neural mechanisms which connects cognitive psychology, neurobiology, neurology, mathematics, physics, linguistics, philosophy and computer science, as well as artificial intelligence, which includes psychophysical experiments, electrophysiological studies of neural systems, functional neuroimaging, and increasingly cognitive genomics and behavioural genetics.
Artificial Intelligence (AI) entails the study of cognitive phenomena in machines one of the realistic desires of artificial intelligence is to put aspects of human intelligence in computer systems. Computer systems are also broadly used as a tool with which to take a look at cognitive phenomena. Computational modelling uses simulations to have a look at how human intelligence may be structured.
- Track 7-1Cognition and Intelligence
- Track 7-2Artificial intelligence
- Track 7-3Collective behaviour
- Track 7-4Language, Learning, and Memory
- Track 7-5Emotional and Social Processes
- Track 7-6Cognitive behavioral therapy
- Track 7-7Cognitive psychology
- Track 7-8Attention, Sensation, and Perception
- Track 7-9computational analysis
- Track 7-10Cognition and Decision-Making
- Track 7-11Brain Stimulation
- Track 7-12Memory Modulation
- Track 7-13computational intelligence
Neurodegeneration marked by gradual loss of neuronal structure and its functions, including death of neurons, The most common neurodegenerative diseases are Alzheimer’s disease and Parkinson’s disease. Degenerative nerve diseases have an effect on many of your body's activities, which includes balance, movement, talking, respiration, and coronary heart function, many of these diseases are genetic, sometimes the reason is a scientific condition which include alcoholism, a tumor, or a stroke, other reasons can also include pollution, chemicals, and viruses, sometimes the purpose is not known. Degenerative nerve diseases include are Alzheimer's disease, Amyotrophic lateral sclerosis, Friedreich's ataxia, Huntington's disease, Lewy body disease, Parkinson's disease and Spinal muscular atrophy
Many neurodegenerative diseases are due to genetic mutations for example the gene CAG encodes for the amino acid glutamine which get mutated to produce repetition of the CAG nucleotide triplet results polyglutamine (polyQ) tract known as polyglutamine diseases. The major examples of neurodegenerative diseases are spinocerebellar ataxias and Huntington's disease.
- Track 8-1Epidemiology of Neurodegenerative disease
- Track 8-2Prion and transmissible spongiform encephalopathies
- Track 8-3Senile plaques
- Track 8-4Beta amyloid
- Track 8-5Proteopathies
- Track 8-6Protein misfolding
- Track 8-7Glutamine and Polyglutamine
- Track 8-8Neurogenesis
- Track 8-9Neurogenetics
- Track 8-10Genetic Mutations
- Track 8-11Genetic epidemiology
- Track 8-12Gene expression
- Track 8-13Disease-relevant variants in Sporadic diseases
- Track 8-14Molecular bases of neurodegenerative disease
- Track 8-15 Epigenetic therapy
Memory Disorders is a collective term marked by damage or injury of neuroanatomical structures that affects the storage, retention and memory recall process of brain, The major causes for memory impairment are Brain strokes, High blood pressure, Medications, Diabetes, Brain trauma or head injury and nutritional deficiencies.
A various types of diseases in which memory storage get halted are Alzheimer's Disease, Corticobasal Degeneration, Creutzfeldt-Jakob Disease, Frontotemporal Dementia, Huntington's Disease, Lewy Body Dementia, Mild Cognitive Impairment, Progressive Supranuclear Palsy and Vascular Dementia
- Track 9-1 Astereognosis
- Track 9-2Traumatic brain injury
- Track 9-3Hyperthymestic syndrome
- Track 9-4recollection of memories
- Track 9-5Wernicke- Korsakoffs syndrome
Neuro-immunology is a vast branch of science that combines the nervous system and immune system together. This field assist in regulating thermogenesis, behavior, sleep, and mood which can be tormented by pro-inflammatory cytokines released by means of activated macrophages and monocytes throughout infection. Neuroinflammation and neuroimmune activation were shown to play a role in the etiology of a variety of neurological problems which includes stroke, Parkinson's and Alzheimer's disease, multiple sclerosis, pain, and AIDS-related dementia, however cytokines and chemokines also modulate CNS function in the absence of overt immunological, physiological, or mental challenges.
- Track 10-1AIDS-related dementia
- Track 10-2mental challenges
- Track 10-3Stroke treatments
Movement disorders refers to a group of nervous system characterized of movement disorders are clinical syndromes with both an excess of motion or a paucity of voluntary and involuntary actions. Individuals with a motion disorder suffer from a breakdown in the normal flow of neurological messages and this results in involuntary muscle motion. Common types of movement disorders are Ataxia, Cervical dystonia, Chorea, Dystonia, Functional movement disorder, Multiple system atrophy, Myoclonus, Progressive supranuclear palsy, Restless legs syndrome, Tardive dyskinesia, Tourette syndrome, Tremor and Wilson's disease.
- Track 11-1Cervical dystonia
- Track 11-2Tourette syndrome
- Track 11-3Tardive dyskinesia
- Track 11-4Restless legs syndrome
- Track 11-5Wilsons disease
Neuroinfectious Disease is an infection of nervous system that covers Brain and Spinal cord. The causative agents for neuroinfections may be Bacteria, fungi, viruses, proins and occasionally protozoa or parasites, infection of brain results in inflammation like encephalitis, meningitis, Progressive multifocal leukoencephalopathy, HIV-associated neurodegeneration, Neurosarcoidosis, HTLV 1 myelopathy hereditary spastic paraparesis and Transverse myelitis.
Symptoms of bacterial or fungal central nervous system infections may include: Severe headache, Back pain, Stiff neck, Confusion, Weakness, Fever, Seizures and Paralysis whereas viral central nervous system Symptoms Fever Irritability, Not wanting to eat, High-pitched cry, Head and neck pain and Seizures.
- Track 12-1Progressive multifocal leukoencephalopathy
- Track 12-2HTLV 1 myelopathy hereditary spastic paraparesis
- Track 12-3meningitis
- Track 12-4encephalitis
- Track 12-5stereotactic neurosurgery
- Track 12-6Neuro-Oncology
Neurology is a branch of science that deals with neurological disorders, diagnosis and treatment of conditions and illness of nervous system. Neurological learning is heavily based on the area of neurobiology, it involves the central and peripheral nervous systems consisting of their coverings, blood vessels, and all effector tissue, inclusive of muscle, Neurological exercise relies closely on the field of neuroscience, that is the medical study of the nervous system.
Neurosurgery is a completely tough surgical specialty wherein strategies and technologies are constantly growing. Minimally-invasive approaches the use of surgical microscopes and endoscopes are increasingly used which achieve similar or better consequences than open surgical operation. The benefits to the patient include much less ache, quicker get better time and minimal scarring.
The main types of illness neurosurgeons treats are: Tumours of the brain, spine and skull, trauma to the head and spinal cord degenerative spinal conditions and prolapsed discs, cerebral (brain) aneurysms and strokes, epilepsy, infections, movement disorders such as Parkinson’s disease , certain psychiatric disorders, congenital conditions such as spina bifida, conditions that affect cerebro-spinal fluid flow such as hydrocephalus, pituitary tumours and neuroendocrine disorders.
- Track 13-1neurovascular surgery
- Track 13-2Seizures
- Track 13-3Neurological Critical Care |
- Track 13-4 Neuro-Trauma
- Track 13-5Neurosurgery Procedures
- Track 13-6traumatology
- Track 13-7Interventional Neuroradiology
- Track 13-8pediatric neurosurgery
- Track 13-9spinal surgery
- Track 13-10Pain
Biomarkers in neurology are an indicator assist in evaluating physiological, pathological or pharmacological affect to a therapeutic intervention. For example Alzheimer's disease biomarkers used to diagnose Alzheimer's disease are neurochemical indicators,
It been said that the beta-amyloid biomarker shows 80% or above specificity, in evaluating AD from dementia. It is believed that it acts as a biomarker will present a future for diagnosis of AD and eventually treatment of AD. Current biomarkers for Alzheimer’s are BACE1, Soluble Aβ precursor protein (sAPP) and Autoantibodies, apart from this neuroimaging like MRI, PET, SPECT, CT and others are used to asses Alzheimer’s, dementias and normal brain aging.
- Track 14-1Neural Tissue Engineering
- Track 14-2Diffusion tensor imaging (DTI)
- Track 14-3Positron emission tomography (PET)
- Track 14-4Magnetic resonance spectroscopy (MRS)
- Track 14-5Single photon emission computed tomography (SPECT)
- Track 14-6Magnetic encephalography (MEG)
- Track 14-7Neurofibrillary Tangles (Nfts)
- Track 14-8Musculoskeletal Imaging
- Track 14-9Biomarker in Neuroimaging
- Track 14-10Neurobiotics
- Track 14-11Computed tomography (CT)
- Track 14-12Molecular and beta-amyloid imaging
- Track 14-13Alzheimers Disease Imaging Biomarkers
- Track 14-14Alzheimers Imaging Consortium
- Track 14-15Amyloid and Tau imaging
- Track 14-16Imaging Animal models
- Track 14-17Imaging and Genetics
- Track 14-18Structural Magnetic Resonance Imaging (MRI)
- Track 14-19Brain Mapping
- Track 14-20Structural imaging biomarkers
- Track 14-21Mild Cognitive Impairment
- Track 14-22Alzheimer’s Disease Imaging Biomarkers
Neuro ophthalmology is a branch that deals with ophthalmic conditions and diseases with neurological problems and different optic nerve disorders. It combines Ophthalmology, Neurology, an radiology together. Neuro-ophthalmology is usually non-procedural, but neuro-ophthalmologists are well expertise to perform eye muscle surgical treatment to treat adult strabismus, optic nerve fenestration for idiopathic intracranial high blood pressure, and botulinum injections for blepharospasm or hemi facial spasm. The General signs of Optic Nerve Dysfunction include: Reduced visual activity all of a sudden, Diplopia and nystagmus, Optic neuritis and Photophobia and Anisocoria.
- Track 15-1Anisocoria
- Track 15-2Photophobia
- Track 15-3Optic neuritis
- Track 15-4nystagmus
- Track 15-5Diplopia
- Track 15-6Reduced visual activity
Health nursing is a well experienced and qualified nurse in mental health that cares for people of all ages with mental conditions like schizophrenia, psychosis, bipolar disorder, depression, anxiety, dementia, and many more. Mental health nurses, especially CPNs, are involved in counselling, which can range from casual chats through to based, one-to-one psychotherapy sessions.
The major duty of a psychiatric nurse is to maintain a healthy and positive therapeutic relationship with patients and direct communication is necessary for developing it.
- Track 16-1Disturbed Thought Process
- Track 16-2Nursing care and practice
- Track 16-3Cognitive assessment of older adults
- Track 16-4Psychological and pharmacological treatments
- Track 16-5Self-care assistance
- Track 16-6Self-care deficit: cognitive and motor function
- Track 16-7Memory clubs
- Track 16-8Nonverbal cues
- Track 16-9Impaired Verbal Communication
- Track 16-10Chronic Confusion
- Track 16-11Nursing Education and Recovery
Neuro-oncology deals with the study of brain and spinal cord tumours, which is usually life threatening. The most common causes of tumours are environmental toxins, genetics, stress, diet, local trauma or injury and inflammation or infection. Types include malignant tumour and benign tumours. The most common symptom is Headaches as result of intracranial pressure an early symptom of brain it get worsened by Valsalva maneuver causing awakening from sleep which is quite different than migraine. In tumours BBB get disrupted, once there is a disruption of the BBB it can be detected by MRI and CT is considered as a main indicator for diagnosis of tumours like meningioma’s, malignant gliomas and brain metastases.
- Track 17-1Tumor markers
- Track 17-2spinal cord neoplasms
- Track 17-3pontine glioma
- Track 17-4Valsalva maneuver
- Track 17-5Brain metastases
- Track 17-6Meningioma’s
Neuropharmacology is the study of drug actions on nervous system, mainly deals in developing the compounds for human’s benefits with psychiatric and neurological disease. Behavioural neuropharmacology focuses on the examine of how drugs have an effect on human behavior (neuropsychopharmacology), along with the study of how drug dependence and addiction affect the human brain. In depth it represents the neural mechanism and interactions of neurotransmitters, neuromodulators, enzymes, second messengers, neuropeptides, necrohormones, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. This interactions study provides an idea which help in developing new treatment and approaches to treat various neurological diseases.
Neurobiochemistry Neurochemistry is the study of neurochemicals which consist of neuromessenger, and other molecules such as psychopharmaceuticals and neuropeptides, that effect the function of neurons by operating of neurons, synapses and neural networks. Neurochemists examine biochemistry and molecular biology of organic compounds in the brain and their functions in neural processes as brain plasticity, neurogenesis, and neural differentiation.
- Track 18-1Neurogenesis and Gliogenesis
- Track 18-2Neuroanatomy
- Track 18-3Clinical Neurophysiology
- Track 18-4Neurobiology
- Track 18-5Electrophysiology
- Track 18-6Glia-Neuron Interactions
- Track 18-7Synaptic Plasticity
- Track 18-8G-Protein Linked Receptors
- Track 18-9Ligand Gated Ion Channels
- Track 18-10Neurotransmitters and Signaling Molecules
- Track 18-11Transplantation and Regeneration
- Track 18-12Developmental Cell Death
- Track 18-13Synaptogenesis
- Track 18-14Stem Cells
- Track 18-15Axon and Dendrite Development
- Track 18-16Postnatal Neurogenesis
- Track 18-17Neural coding
Mood disorders are a set of illnesses that presents a serious change in mood. The major categories are Depression and Bipolar disorders. The subject may experience euphoric, mania, hyperactive, over inflated ego, persistent depressive disorder and seasonal depressive disorders. The Psychiatric Disorders and Mood Disorders is interlinked in its nature it means that the subject with psychiatric disorders has a chance of developing Depression. The other mood disorders are Cyclothymic disorder, premenstrual dysphoric disorder, Persistent depressive disorder (dysthymia), Disruptive mood dysregulation disorder and Depression induced by substance use or medication.
- Track 19-1mania or hypomania
- Track 19-2major depressive disorder
- Track 19-3bipolar disorder
- Track 19-4cyclothymic disorder
- Track 19-5Neurological damage
- Track 19-6Subarachnoid haemorrhage
A stroke or cerebrovascular accident is the unexpectedly growing loss of brain functions because of disturbance in the blood supply to the brain, caused by a blocked or burst blood vessel. In emergency conditions neurological damage get worsened which may results in bleeding (haemorrhagic strokes) and death. The strokes like ischemic stroke, thrombotic stroke, haemorrhagic stroke, intracerebral haemorrhage and subarachnoid haemorrhage are the various types of neuro strokes.
Symptoms includes sudden onset of numbness, weakness, confusion, difficulty speaking, vision loss, dizziness, imbalance and severe headache. It can be prevented by monitoring diet, regulating blood pressure and diabetes levels, physical work out and quitting smoking.
- Track 20-1Haemorrhagic stroke
- Track 20-2Neuro injury
- Track 20-3Neurological damage
- Track 20-4 Subarachnoid haemorrhage
The importance of palliative care extends far past end-of-lifestyles treatment for most cancers sufferers, There are some of crucial regions for palliative care exactly in neurology and a regularly developing call for it now not least because of ever higher lifestyles expectancy charges worldwide.
Example of patients with glioblastoma with this progressive disorder, the need for palliative care constantly will increase. It’s far tough to mention for sure the factor in time at which palliative care need so be initiated, experience shows that factors of palliative medicinal drug are employed and primarily, organized early on in the path of the disorder, even at some point of oncological treatment.
- Track 21-1Supportive care
- Track 21-2Care provider responsibilities
- Track 21-3Emerging Subspecialties in Neurology care
Dementia is a chronic condition of the mental health caused by brain disease or injury marked by memory inabilities, personality impairments, and impaired reasoning. Dementia care practice is a process optimizing patient’s quality of life, functional independence, health, and wellbeing. Accompanying and assisting loved ones and care partners, creating such experiences is vital for promoting the well-being of all events affected by today’s dementia care climate, from those residing with the disorder to their care companions and healthcare providers, all of whom may additionally struggle physically, emotionally, and financially from their diverse relationships to the sickness.
- Track 22-1Assessment and care planning
- Track 22-2Atherosclerosis Of Dementia
- Track 22-3Cognitive training
- Track 22-4Person centered care
- Track 22-5Biomarker research, early detection and precision
- Track 22-6Applied research in dementia
- Track 22-7Technology, innovation and entrepreneurship
- Track 22-8TechnologyResearch-Mobile technology, Home-based technology and Social Networking
- Track 22-9Psychosocial Research in Dementia
- Track 22-10Therapeutic strategies and interventions
- Track 22-11Community care and Family/lay caregiving
- Track 22-12Cross-cultural studies and cultural/linguistic adaptations
- Track 22-13Public Health and Psychosocial Factors/Epidemiology
- Track 22-14Behavioral interventions
- Track 22-15Apolipoprotein E Of Dementia